Ligament Reconstruction Grafts Patents: Top Companies & Trends 2026
Ligament Reconstruction Graft Patents: Who Leads and Where the Claims Sit
36.2% concentration at the top. The five leading assignees account for 1,021 of 2,824 records in scope, but a long tail of single- and few-filing entrants fills the rest of the ranking. Published filings ran from 135 in 2017 down to 10 in the still-filling 2026 window. The most reliable comparison uses complete years only: 2021 to 2024 shows an 86-to-53 record decline, a 38% drop. Because publication typically lags filing by around 18 months, the last one to two years in the chart will fill in further and should not be read as a continued decline yet.
- 1SMITH & NEPHEW INC13.6%
- 2ARTHREX INC11.6%
- 3CONFORMIS INC5.2%
- 4DEPUY MITEK INC2.9%
- 5CAYENNE MEDICAL INC2.8%
See the full ligament reconstruction grafts analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on ligament reconstruction graft patents
Who holds the most patents on ligament reconstruction grafts?
The dataset ranks 100 assignees by patent family count, and the top five together hold 1,021 of 2,824 records in scope, or 36.2%. That leaves the majority of filings spread across a long tail of smaller companies, hospitals and individual inventors. No single company holds a majority share, so freedom-to-operate work needs to check across several leading filers rather than just one.
Is patent filing activity in this field growing or shrinking?
Filings peaked in 2017 at 135 published records and have not returned to that level. Comparing the two most recent complete years available, 2021 and 2024, records fell from 86 to 53, a 38% decline. Because publication lags filing by roughly 18 months, the 2025-2026 figures in any chart are still incomplete and should not be read as confirming a continued slide.
What does US10034675B2 actually cover?
US10034675B2, assigned to Think Surgical, Inc., claims a pre-operative planning system that uses patient scan data to determine optimal bone tunnel placement, then guides a precision drilling system to execute that placement using percutaneously placed registration markers. It sits at the intersection of surgical planning software and robotic drilling hardware rather than the graft or fixation device itself. Anyone building a competing tunnel-placement tool should review its specific claim language on registration-marker use and pre-determined parameter calculation.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Ligament Reconstruction Grafts covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.